Complex Febrile Seizure

Overview

• Definition: A febrile seizure is a seizure occurring in childhood typified by fever, without evidence of intracranial infection or defined cause, and without a history of afebril seizures. A complex febrile seizure is defined by one or more of the following characteristics:
  1. Duration lasting $\ge 15$ minutes.
  2. Focal characteristics (e.g., unilateral limb shaking, eye deviation to one side).
  3. Multiple seizures within a 24-hour period or during the same febrile illness (also referred to as recurrent febrile seizure).
• Epidemiology: Febrile seizures are the most common convulsive disorder in childhood, affecting 2-5% of children. Complex febrile seizures account for approximately 30-35% of all febrile seizures. Peak incidence is between 12-18 months of age, typically occurring in children aged 6 months to 5 years. There is a slight male predominance.
• Classification:
  • Simple Febrile Seizure: Generalized, tonic-clonic, duration $<15$ minutes, occurring once within a 24-hour period.
  • Complex Febrile Seizure: Any of the characteristics listed in the definition (duration $\ge 15$ minutes, focal features, or recurrence within 24 hours).
  • Febrile Status Epilepticus: A febrile seizure lasting $\ge 30$ minutes, or a series of febrile seizures without full recovery of consciousness between episodes, lasting $\ge 30$ minutes. While often overlapping with prolonged complex febrile seizures, this classification emphasizes the prolonged duration and higher risk.

Pathophysiology

• Mechanism: The exact mechanism is not fully understood but is thought to involve the immature developing brain's susceptibility to fever-induced neuronal hyperexcitability. This hyperexcitability may be linked to:
  • Genetic predisposition: Polymorphisms in genes encoding ion channels (e.g., SCN1A), GABA receptors, and inflammasome components have been implicated.
  • Neurotransmitter imbalances: Alterations in GABAergic and glutamatergic systems during fever.
  • Cytokine effects: Fever-induced release of proinflammatory cytokines (e.g., IL-1$\beta$, IL-6, TNF-$\alpha$) can modulate neuronal excitability and lower seizure thresholds.
  • Brainstem-mediated effects: The developing brainstem's role in temperature regulation and seizure propagation.
  • Hypoxic-ischemic damage: Prolonged seizures can lead to metabolic demands exceeding supply, potentially causing neuronal injury.
• Risk Factors:
  • Genetics: Strong family history of febrile seizures (first-degree relative increases risk by 2-3 times).
  • Fever characteristics: Rapid rise in temperature, very high temperature (though the absolute temperature is less important than the rate of rise for initiation).
  • Age: Peak incidence 12-18 months.
  • Viral infections: Human herpesvirus 6 (HHV-6, roseola infantum), influenza, adenovirus, parainfluenza.
  • Vaccinations: MMR (measles-mumps-rubella) vaccine (days 5-12 post-vaccination), DTaP (diphtheria-tetanus-acellular pertussis) vaccine (within 48 hours).
  • Developmental delay: Children with pre-existing developmental delay are at higher risk for complex febrile seizures.
  • Iron deficiency: Some studies suggest a correlation.
• Protective Factors: None definitively proven to prevent the initial occurrence of febrile seizures. Avoiding fever in susceptible children is impractical.

Clinical Presentation

Signs and Symptoms

• Cardinal Features:
  • Seizure activity occurring during a febrile illness (temperature usually $\ge 38^\circ$C or $100.4^\circ$F).
  • Features defining complexity:
    • Prolonged duration: $\ge 15$ minutes, can be up to 30 minutes or longer (febrile status epilepticus).
    • Focal onset/features: Asymmetric motor activity (e.g., jerking of one limb, head deviation, asymmetric posturing), postictal Todd's paresis (transient focal weakness after the seizure).
    • Recurrence: Two or more seizures within 24 hours or the same febrile illness episode.
• Early Signs: May be non-specific signs of fever such as irritability, fussiness, lethargy, or flushed appearance, preceding the seizure.
• Advanced Signs: Prolonged postictal state (drowsiness, confusion), focal deficits (Todd's paresis) following a focal seizure.
• Atypical Presentations: Febrile seizures occurring in the context of an afebrile seizure diagnosis (which would then be classified as an acute symptomatic seizure, not a febrile seizure), or in children outside the typical age range.

Physical Examination

• Inspection:
  • General appearance: Signs of acute illness (e.g., respiratory distress, rashes, dehydration).
  • Seizure activity: While ongoing, observe for focal jerking, eye deviation, generalized tonic-clonic movements, or hypotonia.
  • Postictal state: Level of consciousness (somnolence, confusion, irritability), motor deficits (e.g., hemiparesis).
  • Signs of trauma: Head injury, oral lacerations.
• Palpation:
  • Fontanelle: Bulging or tense fontanelle, especially in infants, suggestive of increased intracranial pressure or meningitis.
  • Neck stiffness: In older children, nuchal rigidity (Brudzinski's or Kernig's signs) raising suspicion of meningitis.
• Special Tests:
  • Neurological examination: Assess for focal neurological deficits, cranial nerve palsies, and altered mental status. These findings, especially if persistent, warrant further investigation.
  • Vital signs: Fever, tachycardia, tachypnea, hypotension.

Diagnostic Approach

History Taking

• Key Questions:
  • Seizure characteristics:
    • Date/time of onset, duration (exact or estimated), type of movement (generalized, focal, asymmetry), eye deviation, loss of consciousness, incontinence, tongue biting.
    • Number of seizures (single vs. multiple within 24 hours/current illness).
  • Fever characteristics:
    • Maximum temperature, timing of fever in relation to seizure, associated symptoms (e.g., rash, cough, vomiting, diarrhea, ear pain).
  • Precipitating factors: Recent illness, vaccinations.
  • Birth history/developmental milestones: Any pre-existing developmental delay or neurological conditions.
  • Past medical history: Previous febrile seizures, afebrile seizures, head trauma, neurological disorders.
  • Family history: Febrile seizures, epilepsy, neurological conditions.
  • Medications: Current medications, recent changes.
  • Red Flags:
    • Absence of fever: Suggests an afebrile seizure.
    • Persistent focal neurological deficits post-seizure: May indicate an underlying structural lesion or acute pathology.
    • Signs of increased intracranial pressure: Vomiting, headache, altered mental status, bulging fontanelle.
    • Meningeal signs: Neck stiffness, photophobia, rash (purpuric).
    • Prolonged postictal unresponsiveness or irritability: Beyond the expected period (usually minutes to a few hours).
    • First seizure at age <6 months or >5 years: Less common for simple febrile seizures, increasing suspicion for other causes.

Laboratory Tests

• First-Line:
  • Not routinely recommended for typical simple febrile seizures. However, for complex febrile seizures, particularly with prolonged duration, focal features, or persistent altered mental status, some tests may be considered.
  • Blood glucose: To rule out hypoglycemia as a reversible cause of seizure, especially in prolonged cases or children who are slow to recover.
  • Electrolytes: If there are concerns for dehydration, vomiting, or diarrhea.
  • Complete Blood Count (CBC) with differential: To assess for signs of severe infection or sepsis.
• Confirmatory:
  • Lumbar Puncture (LP): Considered for complex febrile seizures, especially in infants $<12$ months, or in any child with meningeal signs (severe headache, photophobia, stiff neck), persistent altered mental status, or if prior antibiotic treatment has obscured symptoms of meningitis.
    • American Academy of Pediatrics (AAP) recommendations:
      • Strongly encouraged for infants $<6$ months due to subtle signs of meningitis.
      • Considered for infants 6-12 months due to possibility of occult meningitis.
      • Usually not indicated for children $>12$ months unless there are clear clinical signs of meningitis.
    • CSF studies: Cell count, protein, glucose, Gram stain, bacterial culture, viral PCR (e.g., enterovirus, HSV) if clinically indicated.
• Monitoring:
  • None specifically for febrile seizures after resolution, unless ongoing investigations reveal an underlying condition.

Imaging

• Recommended:
  • Neuroimaging (CT or MRI): Not routinely recommended for complex febrile seizures.
  • Indications for emergent neuroimaging:
    • Evidence of increased intracranial pressure (e.g., papilledema, bulging fontanelle).
    • Persistent focal neurological deficits (e.g., Todd's paresis lasting $>24$ hours).
    • Evidence of head trauma.
    • Suspected intracranial pathology (e.g., tumor, hemorrhage, abscess).
    • Complex febrile status epilepticus with unusually prolonged post-ictal state.
• Advanced:
  • MRI: If an underlying structural brain abnormality is suspected (e.g., tuberous sclerosis, cortical dysplasia), especially if the child develops afebrile seizures later. This is usually not urgent and can be done electively.

Management

Acute Management

• Immediate:
  • Ensure airway patency, adequate breathing, and circulation (ABCs): Position the child on their side (recovery position) to prevent aspiration.
  • Do not restrain the child or put anything in their mouth.
  • Manage hyperthermia: Remove excess clothing, use antipyretics (acetaminophen 15 mg/kg or ibuprofen 10 mg/kg orally/rectally) after the seizure has stopped. Cooling blankets/sponging can be considered after seizure cessation if fever is very high, but are not primary interventions during a seizure.
• Stabilization:
  • Manage seizures lasting $\ge 5$ minutes: Administer anticonvulsant medication.
  • First-line for prolonged seizure: Benzodiazepines.
    • Rectal diazepam: 0.5 mg/kg (max 10 mg), can be repeated once after 5 minutes if seizure persists.
    • Intranasal/buccal midazolam: 0.2-0.3 mg/kg (max 10 mg), also an effective alternative, easier to administer than rectal diazepam for many parents/caregivers.
    • Intravenous (IV) lorazepam: 0.1 mg/kg (max 4 mg) diluted 1:1 with normal saline, given over 2-5 minutes.
    • IV diazepam: 0.2-0.5 mg/kg (max 10 mg).
  • Oxygen supplementation: If desaturation is noted (pulse oximetry $<92-94\%$).
  • IV access: Obtain if possible for medication administration and fluid resuscitation if needed, especially in prolonged seizures.
• Emergency:
  • Febrile status epilepticus (seizure $\ge 30$ minutes or repetitive seizures without recovery):
    • After benzodiazepine administration, consider second-line antiepileptic drugs if seizures persist.
    • Fosphenytoin: 15-20 mg PE (phenytoin equivalents)/kg IV, infused at $\le 150$ mg PE/min.
    • Phenobarbital: 15-20 mg/kg IV, infused at $\le 1-2$ mg/kg/min (max 30-50 mg/min).
    • Levetiracetam: 20-60 mg/kg IV over 10-15 minutes.
    • Continuous EEG monitoring and ICU admission often required.

Chronic Management

• Pharmacological:
  • Intermittent antipyretics for fever: While they do not prevent febrile seizures, they can improve comfort and are generally recommended for fever management.
  • Prophylactic long-term antiepileptic medication: Generally NOT recommended for single or recurrent complex febrile seizures due to potential side effects outweighing the benefits (prevention of subsequent febrile seizures) and lack of evidence for prevention of epilepsy.
    • Exceptions (rarely considered and only after extensive discussion with parents and neurology):
      • Frequent, prolonged, or distressing febrile seizures refractory to other measures.
      • Children with pre-existing neurological deficits or developmental delay, where even small risks are amplified.
      • Daily oral phenobarbital, valproate, or clobazam have been used but carry significant side effects (sedation, hepatotoxicity, behavioral changes).
      • Intermittent benzodiazepines (e.g., oral diazepam) at onset of fever: Can be considered in children with very frequent or prolonged febrile seizures, but efficacy is debated, and compliance is difficult. Often reserved for specific circumstances and usually not the standard of care.
• Non-pharmacological:
  • Parental education and reassurance: Crucial for reducing anxiety. Explain the benign nature, low risk of epilepsy, and strategies for acute management.
  • Fever management: Emphasize comfort measures rather than aggressive temperature reduction for seizure prevention.
  • Identification of underlying infection: Treat underlying cause of fever.
• Monitoring:
  • Future febrile seizure recurrences: Advise parents to closely observe and record details of any future seizures.
  • Developmental surveillance: Continue routine well-child checks.
  • Neurological follow-up: Only if initial complex febrile seizure was atypical, very prolonged, or if developmental concerns arise.

Treatment Algorithms

• First-Line (Acute Seizure):
  1. ABC assessment and support.
  2. Seizure $\ge 5$ minutes: Administer benzodiazepine (rectal diazepam, intranasal/buccal midazolam, or IV lorazepam).
  3. Management of fever: Antipyretics if awake and not aspirating.
• Second-Line (Persistent Seizure/Status Epilepticus):
  1. After 2 doses of benzodiazepines: Consider IV fosphenytoin, phenobarbital, or levetiracetam.
  2. Continuous EEG and ICU monitoring.
• Refractory Cases:
  • Continued status epilepticus after second-line agents often requires continuous IV infusions of midazolam, propofol, or pentobarbital in an ICU setting, with continuous EEG monitoring.

Complications

• Common:
  • Recurrence of febrile seizures: Approximately 30-35% recur, with higher risk if:
    • Age of first febrile seizure $<18$ months.
    • Family history of febrile seizures.
    • Lower temperature at which the seizure occurred.
    • Shorter duration of fever before seizure onset.
  • Anxiety in parents/caregivers: Significant distress and fear of future seizures or epilepsy.
• Serious:
  • Febrile Status Epilepticus (FSE): Prolonged febrile seizures often categorized as complex febrile seizures. While generally benign, FSE may rarely cause excitotoxic neuronal injury, but this is debatable in otherwise healthy children.
  • Underlying serious infection: Meningitis or encephalitis, which the febrile seizure might initially obscure. Early diagnosis and treatment are critical.
• Long-term:
  • Epilepsy: The risk of developing epilepsy after a simple febrile seizure is slightly higher than the general population (1-2% vs. 0.5-1%), but still low. For complex febrile seizures, the risk is further increased to 5-10%, especially if associated with multiple risk factors:
    • Initial febrile seizure at age $<12$ months.
    • Developmentally delayed prior to seizure onset.
    • Family history of epilepsy (not just febrile seizures).
    • The "complex" features itself (prolonged, focal, recurrent).
  • Mesial Temporal Sclerosis (MTS): While some studies suggest a link between prolonged and focal febrile seizures (especially status epilepticus) and subsequent MTS identified in adult patients with drug-resistant temporal lobe epilepsy, this association is complex and not fully understood. It is likely that genetics and pre-existing brain vulnerabilities play a larger role than the febrile seizure itself in the development of MTS.
  • Cognitive/developmental impairment: Generally, febrile seizures, even complex ones, do not cause cognitive impairment or developmental delays in otherwise healthy children. Any observed developmental issues are usually pre-existing.

Prognosis

• Factors:
  • Nature of the febrile seizure: Simple febrile seizures have an excellent prognosis. Complex febrile seizures have a slightly increased risk of epilepsy but generally favorable neurological outcome.
  • Underlying neurological status: Children with pre-existing developmental delays or neurological abnormalities have a worse prognosis regarding future epilepsy risk.
  • Family history of epilepsy: Increases the risk of developing epilepsy.
• Survival: Febrile seizures are rarely fatal, with mortality primarily linked to the underlying cause of fever (e.g., severe infection) rather than the seizure itself.
• Quality of Life: Most children with a history of complex febrile seizures lead normal lives without long-term neurological sequelae. Parental anxiety is a significant factor affecting overall family quality of life.

Prevention

• Primary:
  • No proven methods to prevent the initial occurrence of febrile seizures.
  • Current evidence does not support administering antipyretics to prevent febrile seizures.
• Secondary:
  • Intermittent Use of Antiepileptics (e.g., rectal diazepam): Can be used by parents at the onset of fever to try and abort a seizure in children with a history of frequent, prolonged, or highly distressing febrile seizures. However, issues of compliance, potential side effects (sedation), and debated efficacy limit its widespread use.
  • Continuous Antiepileptic Prophylaxis: As noted above, generally NOT recommended due to unfavorable risk-benefit ratio.
• Tertiary:
  • Parental education: Empowering parents with knowledge about febrile seizures, how to manage an acute seizure, and reassurance about prognosis can significantly reduce anxiety and prevent unnecessary emergency visits.
  • Prompt diagnosis and treatment of underlying fevers: To reduce overall illness burden, but not proven to prevent seizures.

Special Populations

• Pediatric:
  • Infants <6 months: Higher suspicion for meningitis, lower threshold for LP.
  • Toddlers (12-18 months): Peak incidence.
  • Children with developmental delay: Higher risk of recurrence and subsequent epilepsy. Counseling should address this increased risk.
• Geriatric: Not applicable as febrile seizures are a childhood phenomenon. Seizures with fever in adults suggest other etiologies (e.g., meningoencephalitis, severe systemic infection with secondary encephalopathy, drug withdrawal).
• Pregnancy: Not applicable.
• Comorbidities:
  • Children with known neurological conditions (e.g., cerebral palsy, tuberous sclerosis): seizures during fever are classified as acute symptomatic seizures, not "febrile seizures," and management is directed at the underlying condition and seizure control.
  • Immunocompromised children: Increased risk of severe underlying infections; diagnostic workup may need to be more aggressive.

Clinical Pearls

• Diagnostic:
  • Focal features or prolonged duration are the key markers of "complex": These warrant a more careful workup than simple febrile seizures, especially regarding meningitis in younger children.
  • LP is crucial in infants <12 months with complex febrile seizures, or any child with meningeal signs, regardless of age.
  • Neuroimaging is rarely urgent for complex febrile seizures unless there are persistent focal deficits or signs of increased ICP.
  • A normal postictal period is reassuring: Expect drowsiness for minutes to a few hours. Persistent unresponsiveness or irritability is a red flag.
• Treatment:
  • Focus on acute seizure control and parental reassurance: Most febrile seizures are benign.
  • Benzodiazepines are the cornerstone of acute prolonged seizure management.
  • Antipyretics are for comfort, not seizure prevention.
  • Routine daily anti-seizure medication is generally not recommended.
• Pitfalls:
  • Over-investigation: Avoid unnecessary lumbar punctures or imaging in well-appearing children after a resolved complex febrile seizure without specific red flags.
  • Misinformation to parents: Do not overemphasize the risk of epilepsy; provide an accurate, reassuring prognosis.
  • Delay in treating febrile status epilepticus: Prolonged seizures have a higher risk of complications, though still generally low in febrile seizures.

Recent Updates

• Guidelines:
  • The American Academy of Pediatrics (AAP) last updated its practice guideline for the neurodiagnostic evaluation of the child with a simple febrile seizure in 2011, and these principles are largely extended to complex febrile seizures for diagnostic approaches. Newer guidelines often integrate complex febrile seizures into broader discussions of pediatric status epilepticus.
  • International League Against Epilepsy (ILAE) definitions and classifications continue to evolve, but core definitions for febrile seizures remain largely stable.
• Evidence:
  • Ongoing research continues to explore the genetic predispositions to febrile seizures, seeking to identify specific gene mutations that might render certain children more susceptible or predict those at higher risk for subsequent epilepsy.
  • The link between prolonged febrile seizures, febrile status epilepticus, and later development of mesial temporal sclerosis and temporal lobe epilepsy remains an active area of investigation, with increasing evidence suggesting that genetic susceptibilities and pre-existing subtle brain abnormalities may be more significant than the febrile seizure itself as a causative factor.
• Controversies:
  • The utility of antipyretics for prevention of recurrent febrile seizures: While they improve comfort, robust evidence for seizure prevention is lacking.
  • Optimal timing and criteria for lumbar puncture in children between 6 and 12 months with complex febrile seizures: This remains an area of clinical judgment and sometimes debate, balancing the risk of missed meningitis against the invasiveness of the procedure.
  • The precise risk of epilepsy post-complex febrile seizure: While generally higher than simple febrile seizures, the exact probability is influenced by multiple interactive factors and can be challenging to predict definitively for an individual child.

Key References

• Guidelines:
  • American Academy of Pediatrics. Committee on Quality Improvement, Subcommittee on Febrile Seizures. Practice parameter: The neurodiagnostic evaluation of the child with a first simple febrile seizure. Pediatrics 2011;127:389-94.
  • Shinnar S, Glauser TA, Pellock JM, et al. FEBSTAT study: Design and methodology. Epilepsia 2012;53 Suppl 4:26-34.
  • NICE guideline [NG143]: Epilepsies in children, young people and adults. National Institute for Health and Care Excellence. 2021.
• Studies:
  • Nelson KB, Ellenberg JH. Prognosis in children with febrile seizures. Pediatrics 1978;61:720-7.
  • Shinnar S, Pellock JM, Moshe SL, Nordli DR Jr. In search of a solution to the febrile seizure puzzle. Epilepsia 2012;53 Suppl 4:1-2.
  • Arzimanoglou A, et al. Focal epilepsy in children including febrile seizures. ILAE commission on Pediatric Epilepsy. Epileptic Disord 2005;7(2):107-16.
• Reviews:
  • Camfield PR, Camfield CS. Approach to the child with a "febrile seizure". UpToDate. Accessed 2023.
  • Varma K, Shah SS. Febrile Seizures. In: Kleigman RM, Stanton BF, St. Geme JW, Schor NF, Behrman RE, eds. Nelson Textbook of Pediatrics. 21st ed. Philadelphia, PA: Elsevier; 2020:chap 608.

---

Disclaimer: This information is intended for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider for any questions regarding your medical condition. Clinical decisions should always be made in the context of the individual patient's clinical presentation, comorbidities, and in consultation with expert opinion.